2023
DOI: 10.1080/13696998.2023.2224168
|View full text |Cite
|
Sign up to set email alerts
|

Strategic management and organizational culture of medical device companies in relation to corporate performance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 62 publications
0
1
0
Order By: Relevance
“…The research's null hypothesis posits that culture has a beneficial impact on innovative capabilities. Research has shown that this type of culture is strongly linked to an innovation culture [108][109][110], which, in turn, enhances creative ability [110]. In addition, a culture that encourages openness, creativity, risk-taking, and entrepreneurial spirit motivates employees to act in a way that prioritizes innovation as a core business concept [111].…”
Section: Corporate Culture and Innovation Capabilitiesmentioning
confidence: 99%
“…The research's null hypothesis posits that culture has a beneficial impact on innovative capabilities. Research has shown that this type of culture is strongly linked to an innovation culture [108][109][110], which, in turn, enhances creative ability [110]. In addition, a culture that encourages openness, creativity, risk-taking, and entrepreneurial spirit motivates employees to act in a way that prioritizes innovation as a core business concept [111].…”
Section: Corporate Culture and Innovation Capabilitiesmentioning
confidence: 99%
“…Enterprises should create an appropriate corporate culture because, according to the research of Park et al (2023), corporate culture can increase business performance. Additionally, according to Khan et al (2023), it is a key aspect of sustainability.…”
Section: Entrepreneurship and Sustainability Issuesmentioning
confidence: 99%
“…For example, in order to understand the wider East Asian and Association of South‐East Asian Nations (ASEAN) countries context, one should know that legislation on medical devices marketing approval and reimbursement, unlike with pharmaceuticals, remains exceptionally diverse and heterogeneous across this vast region [ 29 ]. Furthermore, safety efficacy and quality requirements are not uniform across these jurisdictions [ 30 ]. Such a landscape creates room for different interpretations by the manufacturers and regulatory authorities [ 31 ].…”
Section: Editorialmentioning
confidence: 99%